King Rachel K. 4

4 · NOVAVAX INC · Filed Jun 13, 2023

Form 4

Period: 2023-06-10

Director

Transactions

Exercise/Conversion
Common Stock
2023-06-10+3,100→ 10,050 total
Award
Stock Option (Right to Buy)
2023-06-12+7,710→ 7,710 total
Exercise: $7.78From: 2024-06-12Exp: 2033-06-12→ Common Stock (7,710 underlying)
Exercise/Conversion
Restricted Stock Units
2023-06-10−3,100→ 0 total
→ Common Stock (3,100 underlying)
Award
Restricted Stock Units
2023-06-12+6,670→ 6,670 total
→ Common Stock (6,670 underlying)

Holdings

Footnotes (5)

[F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
[F2]Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child.
[F3]One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date.
[F4]One hundred percent (100%) of the shares subject to this option grant under the Plan will vest one (1) year from the June 12, 2023 grant date (the "Grant Date") subject to continued service on the Company's Board of Directors through the vesting date.
[F5]One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date.

Documents

1 file